首页> 外文期刊>The Biochemical Journal >Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations.
【24h】

Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations.

机译:人谷氨酸脱氢酶(GDH)变构调控突变的表达,纯化和表征。

获取原文
获取原文并翻译 | 示例
           

摘要

Glutamate dehydrogenase (GDH) catalyses the reversible oxidative deamination of l-glutamate to 2-oxoglutarate in the mitochondrial matrix. In mammals, this enzyme is highly regulated by allosteric effectors. The major allosteric activator and inhibitor are ADP and GTP, respectively; allosteric activation by leucine may play an important role in amino acid-stimulated insulin secretion. The physiological significance of this regulation has been highlighted by the identification of children with an unusual hyperinsulinism/hyperammonaemia syndrome associated with dominant mutations in GDH that cause a loss in GTP inhibition. In order to determine the effects of these mutations on the function of the human GDH homohexamer, we studied the expression, purification and characterization of two of these regulatory mutations (H454Y, which affects the putative GTP-binding site, and S448P, which affects the antenna region) and a mutation designed to alter the putative binding site for ADP (R463A). The sensitivity to GTP inhibition was impaired markedly in the purified H454Y (ED(50), 210 microM) and S448P (ED(50), 3.1 microM) human GDH mutants compared with the wild-type human GDH (ED(50), 42 nM) or GDH isolated from heterozygous patient cells (ED(50), 290 and 280 nM, respectively). Sensitivity to ADP or leucine stimulation was unaffected by these mutations, confirming that they interfere specifically with the inhibitory GTP-binding site. Conversely, the R463A mutation completely eliminated ADP activation of human GDH, but had little effect on either GTP inhibition or leucine activation. The effects of these three mutations on ATP regulation indicated that this nucleotide inhibits human GDH through binding of its triphosphate tail to the GTP site and, at higher concentrations, activates the enzyme through binding of the nucleotide to the ADP site. These data confirm the assignment of the GTP and ADP allosteric regulatory sites on GDH based on X-ray crystallography and provide insight into the structural mechanisms involved in positive and negative allosteric control and in inter-subunit co-operativity of human GDH.
机译:谷氨酸脱氢酶(GDH)催化线粒体基质中L-谷氨酸可逆氧化脱氨为2-氧代戊二酸。在哺乳动物中,这种酶受到变构效应物的高度调节。主要的变构活化剂和抑制剂分别是ADP和GTP。亮氨酸的变构活化可能在氨基酸刺激的胰岛素分泌中起重要作用。鉴定患有异常高胰岛素血症/高氨血症综合征的儿童与导致GTP抑制作用丧失的GDH显性突变有关,已突显了该法规的生理学意义。为了确定这些突变对人GDH同型六聚体功能的影响,我们研究了其中两个调控突变(H454Y和S448P的表达,纯化和特​​征),H454Y影响假定的GTP结合位点,S448P影响天线区域)和旨在改变ADP的假定结合位点的突变(R463A)。与野生型人GDH(ED(50),42)相比,纯化的H454Y(ED(50),210 microM)和S448P(ED(50),3.1 microM)人GDH突变体对GTP抑制的敏感性显着降低。 nM)或GDH从杂合的患者细胞中分离(分别为ED(50),290和280 nM)。这些突变不会影响对ADP或亮氨酸刺激的敏感性,从而证实它们特异性干扰抑制性GTP结合位点。相反,R463A突变完全消除了人GDH的ADP激活,但对GTP抑制或亮氨酸激活几乎没有影响。这三个突变对ATP调节的影响表明,该核苷酸通过三磷酸尾部与GTP位点的结合来抑制人GDH,并在较高浓度下通过核苷酸与ADP位点的结合来激活酶。这些数据证实了基于X射线晶体学对GDH的GTP和ADP变构调节位点的分配,并提供了对参与人类GDH的正向和负向变构控制和亚基间协同作用的结构机制的深入了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号